A process for the preparation of a catalyst from a catalytic precursor comprising a support based on alumina and/or silica-alumina and/or zeolite and comprising at least one element of group VIB and optionally at least one element of group VIII, by impregnation of said precursor with a solution of a C1-C4 dialkyl succinate. An impregnation step for impregnation of said precursor which is dried, calcined or regenerated, with at least one solution containing at least one carboxylic acid other than acetic acid, then maturing and drying at a temperature less than or equal to 200° C., optionally a heat treatment at a temperature lower than 350° C., followed by an impregnation step with a solution containing at least one C1-C4 dialkyl succinate followed by maturing and drying at a temperature less than 200° C. without subsequent calcination step. The catalyst is used in hydrotreatment and/or hydroconversion.

The present disclosure relates to a composition that includes a first oxide having a phosphate, a ratio of Brønsted acid sites to Lewis acid sites between 0.05 and 1.00, and a total acidity between 50 μmol/g and 300 μmol/g, where the phosphate is at least one of a functional group covalently bonded to the first oxide and/or an anion ionically bonded to the first oxide.

The solar-powered oxygen production system for hospitals is useful for producing oxygen in hospital settings without the need for an external power source. The system includes one or more photovoltaic (PV) solar panels mounted on the roof of a hospital and an oxygen production system housed within the equipment room of the hospital. The solar panels provide the electrical power needed for the oxygen production system. The solar panels are mounted on the roof using solar panel supports. The number of panels and the power output of each panel can be selected depending on the electrical power requirements of the oxygen production system. The oxygen production system includes an LED for activating a black phosphorous catalyst in the atmospheric air to convert water vapor in the air into hydrogen and oxygen.

The solar-powered oxygen production system for hospitals is useful for producing oxygen in hospital settings without the need for an external power source. The system includes one or more photovoltaic (PV) solar panels mounted on the roof of a hospital and an oxygen production system housed within the equipment room of the hospital. The solar panels provide the electrical power needed for the oxygen production system. The solar panels are mounted on the roof using solar panel supports. The number of panels and the power output of each panel can be selected depending on the electrical power requirements of the oxygen production system. The oxygen production system includes an LED for activating a black phosphorous catalyst in the atmospheric air to convert water vapor in the air into hydrogen and oxygen.

Methods use a catalytic composition built up from a ceramic material including a catalytic material and a first inorganic binder and a second inorganic binder and a catalytic structure made thereof. Preferably, the structure is made by a colloidal ceramic shaping technique. The structure is used for catalytic or ion exchange applications. The catalytic structures have excellent mechanical, physicochemical and catalytic properties.

Methods use a catalytic composition built up from a ceramic material including a catalytic material and a first inorganic binder and a second inorganic binder and a catalytic structure made thereof. Preferably, the structure is made by a colloidal ceramic shaping technique. The structure is used for catalytic or ion exchange applications. The catalytic structures have excellent mechanical, physicochemical and catalytic properties.

An object of the present invention is to provide a new form of adsorbent suitable for a motor vehicle canister. An activated carbon fiber sheet satisfies one or two or more of conditions for indices, such as a specific surface area, a pore volume of pores having a given pore diameter, and a sheet density. An embodiment, for example, may have: a specific surface area ranging from 1400 to 2200 m.sup.2/g; a pore volume ranging from 0.20 to 1.20 cm.sup.3/g for pores having pore diameters of more than 0.7 nm and 2.0 nm or less; and a sheet density ranging from 0.030 to 0.200 g/cm.sup.3.

A disproportionation and transalkylation catalyst can be used in the catalytic conversion of alkyl aromatic hydrocarbons. The catalyst contains an acidic molecular sieve, a first metal component immobilized on the acidic molecular sieve and an oxide additive. The first metal contained in the first metal component is at least one selected from the group of Group VB metals, Group VIB metals and Group VIIB metals, the catalyst has a mediate strong acid content of 0.05-2.0 mmol/g of catalyst, and a ratio of the mediate strong acid content to the total acid content of 60-99%. When used in the catalytic conversion of alkyl aromatic hydrocarbons, the catalyst exhibits high reaction activity, low aromatic hydrocarbon loss rate.

Provided is a method for manufacturing a single-atom catalyst supported on a carbon support, including treating a mixture of a precursor of a carbon support and a precursor of a hetero element other than carbon through a dry vapor phase process, thereby supporting, on a carbon support, a single-atom catalyst containing a hetero element other than carbon.

Provided is a method for manufacturing a single-atom catalyst supported on a carbon support, including treating a mixture of a precursor of a carbon support and a precursor of a hetero element other than carbon through a dry vapor phase process, thereby supporting, on a carbon support, a single-atom catalyst containing a hetero element other than carbon.